CLINICAL OUTCOMES OF MELANOMA BRAIN METASTASES TREATED WITH NIVOLUMAB AND IPILIMUMAB ALONE VERSUS NIVOLUMAB AND IPILIMUMAB WITH STEREOTACTIC RADIOSURGERY

被引：0
|
作者：
Tang, Joseph [1 ]
Mills, Matthew [2 ]
Dohm, Ammoren [2 ]
Khushalani, Nikhil [3 ]
Forsyth, Peter [3 ]
Vogelbaum, Michael A. [4 ]
Wuthrick, Evan [2 ]
Yu, Hsiang-Hsuan Michael [2 ]
Oliver, Daniel [2 ]
Liu, James [5 ]
Ahmed, Kamran [2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Ann Arbor, MI USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RADT-07
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Improved clinical response in patients with advanced melanoma treated with nivolumab combined with ipilimumab compared to ipilimumab alone
    Hodi, F. Stephen
    Postow, Michael A.
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth
    McDermott, David
    Linette, Gerald
    Meyer, Nicolas
    Giguere, Jeffrey
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Emstoff, Marc S.
    Minor, David R.
    Salama, April
    Taylor, Matthew H.
    Rollin, Linda
    Horak, Christine
    Gagnier, Paul
    Wolchok, Jedd D.
    CANCER RESEARCH, 2015, 75
  • [22] Ipilimumab and stereotactic radiosurgery with cyberknife in melanoma brain metastases
    Borzillo, V.
    Di Franco, R.
    Falivene, S.
    Martino, A.
    Ravo, V.
    Totaro, G.
    Giugliano, F. M.
    Ascierto, P. A.
    Grimaldi, A. M.
    Festino, L.
    Simeone, E.
    Vanella, V.
    Cammarota, F.
    Giannarelli, D.
    Muto, P.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S389 - S390
  • [23] Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Chapman, Paul B.
    Jayaprakasam, Vetri Sudar
    Panageas, Katherine S.
    Callahan, Margaret
    Postow, Michael A.
    Shoushtari, Alexander N.
    Wolchok, Jedd D.
    Warner, Allison Betof
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [24] Combined Nivolumab and Ipilimumab Is an Effective Treatment for Melanoma Brain Metastases
    Traylor, Jeffrey I.
    Kuo, John S.
    NEUROSURGERY, 2019, 84 (03) : E134 - E135
  • [25] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Mansouri, Alireza
    Moraes, Fabio Y.
    Zadeh, Gelareh
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178
  • [26] The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab
    Cohen-Inbar, Or
    Shih, Han-Hsun
    Xu, Zhiyuan
    Schlesinger, David
    Sheehan, Jason P.
    JOURNAL OF NEUROSURGERY, 2017, 127 (05) : 1007 - 1014
  • [27] Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab
    Olson, Adam C.
    Thomas, Samantha
    Qin, Rosie
    Singh, Bhavana
    Salama, Joseph K.
    Kirkpatrick, John
    Salama, April K. S.
    MELANOMA MANAGEMENT, 2016, 3 (03) : 177 - 186
  • [28] Utilization of Brain-Directed Therapy for Patients with Melanoma Brain Metastases Treated with Ipilimumab and Nivolumab
    Kleber, T.
    Srinivasan, S.
    Davies, M.
    Tawbi, H. A.
    Glitza, I.
    Ferguson, S.
    Beckham, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E245 - E245
  • [29] Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
    Hodi, Frank Stephen
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Cowey, Charles Lance
    Lao, Christopher D.
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Hill, Andrew
    Hogg, David
    Marquez-Rodas, Ivan
    Jiang, Joel
    Rizzo, Jasmine
    Larkin, James
    Wolchok, Jedd D.
    LANCET ONCOLOGY, 2018, 19 (11): : 1480 - 1492
  • [30] Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis
    Bodensohn, Raphael
    Werner, Simone
    Reis, Jonas
    Escudero, Montserrat Pazos
    Kaempfel, Anna -Lena
    Hadi, Indrawati
    Forbrig, Robert
    Manapov, Farkhad
    Corradini, Stefanie
    Belka, Claus
    Theurich, Sebastian
    Heinzerling, Lucie
    Schlaak, Max
    Niyazi, Maximilian
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39
12345